miR-31 negatively regulates the noncanonical NF-κB pathway by targeting NF-κB-inducing kinase (NIK), and is often silenced in ATLL cells through Polycomb-mediated epigenetic miRNA silencing [151]. Here, NFKB1 is linked to adult T-cell leukemia/lymphoma.